课题基金 / 基金详情

CHIRAL CROTYLBORONATIES; METHODOLOGY AND SYNTHESIS

CHIRAL CROTYLBORONATIES; METHODOLOGY AND SYNTHESIS
手性巴豆基硼酸酯;
批准号:
3294875
负责人:
WILLIAM R ROUSH
金额:
$14.59万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-02-01 至 1992-01-31

项目摘要

项目成果

WILLIAM R ROUSH的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The efficient stereo- and enantioselective construction of complex arrays of acyclic stereocenters constitutes one of the most intriguing challenges in modern synthetic organic chemistry. The multitude of these acyclic stereocenters in macrolides, polyether antibiotics and numerous other biologically active natural products behooves the organic chemist to devise methodology that is practical, efficient and applicable to a board spectrum of problems. The studies we propose are directed towards the development of a general solution to the polypropionate (-CHMe-CHOH-CHMe-) and polyacetate (-CHOH-CH2-CHOH) acyclic stereochemical problems. In preliminary work we have developed a class of tartrate ester modified allyl and crotylboronic esters that undergo highly enantioselective and diastereoselective reactions with achiral and chiral aldehydes. In studies planned for the next four year period, we intend to explore the scope and generality of these reagents, probe the origin of asymmetry and develop second generation reagents with increased, near perfect levels of enantioselectivity. We also intend to apply this methodology in the synthesis of natural products of propiogenic biosynthetic origin. Suggested targets include the ansa chain of streptovaricin D (an ansamycin antibiotic with significant anti-viral activity) and bafilomycin A1 (a member of the novel hygrolide family of macrolides that have a range of significant biological properties including antiparasitic and antifungal activity). The synthetic objectives will receive lower priority than the methodological investigations. If our goals are met, we will have developed a family of chiral allylboronates that function as highly enantioselective acetate and propionate enolate equivalents, and will have greatly expanded the scope of reagents available to the organic chemist for the enantio- and diastereoselective construction of complex, biologically active molecules.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
  • 批准号:
    8840911
  • 项目类别:
  • 资助金额:
    $49.2万
  • 财政年份:
    2014
  • 负责人:
    WILLIAM R ROUSH
  • 依托单位:
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
  • 批准号:
    8631767
  • 项目类别:
  • 资助金额:
    $48.43万
  • 财政年份:
    2014
  • 负责人:
    WILLIAM R ROUSH
  • 依托单位:
Targeting Casein Kinase 1d/e (CK1d/1e) in Cancer Therapeutics
  • 批准号:
    9049453
  • 项目类别:
  • 资助金额:
    $49.2万
  • 财政年份:
    2014
  • 负责人:
    WILLIAM R ROUSH
  • 依托单位:
SAR Analysis/Med Chem (Florida)
  • 批准号:
    8538725
  • 项目类别:
  • 资助金额:
    $94.88万
  • 财政年份:
    2012
  • 负责人:
    WILLIAM R ROUSH
  • 依托单位: